MDB Capital Holdings, LLC Class A AI Stock Analysis
Want to see MDBH full AI Analyst Report?
MDB Capital Holdings, LLC Class A (MDBH) AI Stock Analysis
MDB Capital Holdings, LLC Class A
(NASDAQ:MDBH)
The overall score of 49 reflects a high-risk, early-stage company with a stark contrast between its precarious financial health and an optimistic strategic roadmap. The most significant positive factor is the management's vision and the potential of its core assets, as detailed in the earnings call, which provides a speculative upside. This is heavily counterbalanced by the critical financial weaknesses: a rapid cash burn rate and deep unprofitability that threaten the company's survival, reinforced by a bearish technical trend. The strong, debt-free balance sheet is the key mitigating factor, providing a temporary buffer against these headwinds.
MDB Capital Holdings, LLC Class A (MDBH) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $15.14M
- Dividend Yield
- ―
- Average Volume (3M)
- 3,688
- Price to Earnings (P/E)
- -0.4
- Beta (1Y)
- 0.75
- Revenue Growth
- 91.75%
- EPS Growth
- -385.99%
- Country
- US
- Employees
- 14
- Sector
- Financial
- Sector Strength
- 68
- Industry
- Financial - Capital Markets
MDB Capital Holdings, LLC Class A Business Overview & Revenue Model
Company Description
MDB Capital Holdings, LLC functions primarily as a broker-dealer through its subsidiary operations. The company's activities are divided into two main areas: Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer...
MDB Capital Holdings, LLC Class A Earnings Call Summary
The call was strongly optimistic about the progress and potential of MDB's four core assets, highlighting operational buildout, AI-enabled capabilities, lower eXoZymes manufacturing costs, planned clinical milestones for Paulex, and expected asset distributions in 2027. However, management also emphasized difficult capital markets, financing and timing risk, delayed Paulex dosing, limited eXoZymes trading activity, the need to reduce operating spend, and weak market recognition of portfolio-company performance. The positive strategic and operational commentary outweighed the acknowledged challenges, though the outlook remains dependent on financings, partnerships, clinical results, and improved market conditions.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management said it had been hoping to launch 2 to 3 to 4 big ideas a year, but will focus on its 4 key assets and expects distributions in 2027, with a goal to deliver as much out to the shareholders in 2027 as possible. Public Ventures, following an almost 5-year journey, is in discussions with several highly qualified folks and management hopes to conclude a transaction; there are approximately 100 clearing broker-dealers in the U.S. PatentVest plans to complete a financing to scale marketing and can process 1,000 patent applications a year, compared with 50 or 100 patents needed by some companies, and demonstrated taking an invention through the process in 1 day; it was built over 2.5 years to serve a $30 billion global market. eXoZymes reduced potential production costs from $3,500 a kilo to under $1,000 a kilo, expects partnerships and announcements shortly, and believes compounds could sell hundreds of millions, if not billions of dollars of product and create billions of dollars of value. Paulex was about 2 months behind its target, with first patients expected to be dosed in December, and the company would like to go public in the first half of next year; its market is described as potentially a $100 billion market and growing over the next few years. MDB reported fee income of about $4.2 million for the first 9 months, about $8.3 million in operating cash, and just under 11 million shares outstanding, while aiming to reduce operating spend significantly and extend its runway.
MDB Capital Holdings, LLC Class A Financial Statement Overview
Summary
Financial performance is highly polarized. The balance sheet is a fortress with zero debt and a solid equity base (Score: 72), providing a critical runway. However, this is severely undermined by deep and worsening cash burn (Score: 15) and significant net losses despite rapid revenue growth (Score: 18). The company's survival hinges on stemming the cash bleed before its equity is depleted.
Income Statement
18Very NegativeBalance Sheet
72PositiveCash Flow
15Very Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.01M | 4.28M | 2.22M | 4.23M | 1.12M | 0 |
| Gross Profit | 3.17M | -10.69M | -17.84M | -4.39M | -1.71M | -1.97M |
| EBITDA | -22.70M | -16.95M | 12.33M | -9.76M | -5.97M | -5.67M |
| Net Income | -34.25M | -21.25M | 11.69M | -6.97M | -5.31M | -15.10M |
Balance Sheet | ||||||
| Total Assets | 37.49M | 63.74M | 71.98M | 42.99M | 25.70M | 8.25M |
| Cash, Cash Equivalents and Short-Term Investments | 10.62M | 13.22M | 20.44M | 6.11M | 4.95M | 6.23M |
| Total Debt | 524.00K | 609.00K | 711.50K | 2.42M | 1.42M | 720.63K |
| Total Liabilities | 1.43M | 3.16M | 1.90M | 5.67M | 2.59M | 1.49M |
| Stockholders Equity | 36.18M | 60.69M | 70.16M | 37.31M | 22.64M | 6.24M |
Cash Flow | ||||||
| Free Cash Flow | -8.18M | -5.73M | -8.49M | -7.60M | -6.77M | -6.26M |
| Operating Cash Flow | -8.05M | -5.68M | -9.04M | -7.16M | -6.57M | -5.83M |
| Investing Cash Flow | 863.10K | -49.00K | 22.89M | -8.20M | -16.38M | -423.39K |
| Financing Cash Flow | 0 | 0 | 69.30K | 17.76M | 21.68M | 0 |
MDB Capital Holdings, LLC Class A Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MDBH, the sentiment is Negative. The current price of 1.46 is below the 20-day moving average (MA) of 1.57, below the 50-day MA of 2.00, and below the 200-day MA of 2.91, indicating a bearish trend. The MACD of -0.14 indicates Negative momentum. The RSI at 41.77 is Neutral, neither overbought nor oversold. The STOCH value of 2.23 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MDBH.
MDB Capital Holdings, LLC Class A Risk Analysis
MDB Capital Holdings, LLC Class A disclosed 70 risk factors in its most recent earnings report. MDB Capital Holdings, LLC Class A reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksMDB Capital Holdings, LLC Class A Peers Comparison
Overall Rating
COHN62Neutral
MDBH49Neutral
DOMH39Underperform
SIEB39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 68Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
| 62Neutral | $29.05M | 0.91 | 33.48% | 42.87% | -43.28% | 290.47% | |
| 49Neutral | $15.64M | -0.44 | -67.54% | ― | 91.75% | -385.99% | |
| 39Underperform | $20.73M | -0.07 | -536.69% | ― | -11.35% | -283.65% | |
| 39Underperform | $69.67M | -19.55 | -3.88% | ― | 13.48% | -146.43% |
* Financial Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MDBH | MDB Capital Holdings, LLC Class A | 1.46 | -2.05 | -58.40% | |
| COHN | Cohen & Company | 8.63 | -3.64 | -29.67% | |
| SIEB | Siebert Financial | 1.65 | -1.26 | -43.30% | |
| DOMH | Dominari Holdings Inc. | 0.87 | -2.91 | -77.06% | |
| TOP | Zhong Yang Financial Group Ltd. | 16.99 | 11.72 | 222.15% | |
| GSIW | Garden Stage Ltd. | 10.27 | -20.15 | -66.24% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 18, 2026
